NAMD Submits Comments on Medicaid Drug Rebate Program Proposed Rule
On July 25, NAMD submitted comments on CMS's proposed rule on the Medicaid Drug Rebate Program (MDRP).
Letter ·
NAMD Asks for Medicaid to be Exempt from OIG Pharmacy Rebate Rule
NAMD requested that the Health and Human Services Office of the Inspector General not move forward with including Medicaid plans in a proposed rule exempting negotiated pharmacy rebates from the anti-kickback statute’s safe harbor.
In 2019, the Health and Human Services Office of the Inspector General proposed to significantly change the treatment of managed care plan negotiated pharmacy rebates under the anti-kickback statute. In this letter, NAMD explains why such a change would create significant volatility for state Medicaid programs and likely increase state pharmacy spending. NAMD asked for Medicaid plans to be exempted from this proposal.
Related resources
Prescription Drug Spending: What’s Coming Next for Medicaid and How Can States Prepare?
Experts at the NAMD Fall Conference discussed challenges with high-cost drugs.
NAMD Comments on Medicare’s Proposed Coverage Determination for Alzheimer’s Drug
On February 9, 2022, NAMD submitted comments on Medicare’s proposed National Coverage Determination (NCD) of Coverage with Evidence...
Stay Informed
Drop us your email and we’ll keep you up-to-date on Medicaid issues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.